MHENCR
gene geneOn this page
Summary
MHENCR (melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489, HGNC:53110) is a long non-coding RNA gene on chromosome 20q13.33.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53110 |
| Approved symbol | MHENCR |
| Name | melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489 |
| Location | 20q13.33 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000232442 |
| Ensembl biotype | lncRNA |
| Entrez | 100505771 |
| RNAcentral | URS00008E398E — lncRNA, 793 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 lncRNA
ENST00000411579, ENST00000449500, ENST00000685151, ENST00000686481, ENST00000825379, ENST00000825380, ENST00000825381, ENST00000825382, ENST00000825383
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000411579 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004235585 | 63628269 | 63628712 |
| ENSE00004235592 | 63627209 | 63627392 |
Expression profiles
Bgee: expression breadth ubiquitous, 136 present calls, max score 98.69.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.1602 / max 386.7451, expressed in 1796 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 185842 | 14.3149 | 1760 |
| 185841 | 3.8453 | 1428 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| thymus | UBERON:0002370 | 98.69 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 96.70 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 96.58 | gold quality |
| thyroid gland | UBERON:0002046 | 96.25 | gold quality |
| quadriceps femoris | UBERON:0001377 | 95.93 | gold quality |
| spleen | UBERON:0002106 | 94.78 | gold quality |
| right uterine tube | UBERON:0001302 | 93.26 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 93.16 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 92.40 | gold quality |
| cerebellar cortex | UBERON:0002129 | 92.26 | gold quality |
| cerebellum | UBERON:0002037 | 92.13 | gold quality |
| cerebellar vermis | UBERON:0004720 | 91.65 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 91.57 | gold quality |
| blood | UBERON:0000178 | 91.45 | gold quality |
| granulocyte | CL:0000094 | 91.17 | gold quality |
| metanephros cortex | UBERON:0010533 | 90.43 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 89.62 | gold quality |
| pituitary gland | UBERON:0000007 | 89.51 | gold quality |
| right lung | UBERON:0002167 | 89.33 | gold quality |
| adenohypophysis | UBERON:0002196 | 89.02 | gold quality |
| spinal cord | UBERON:0002240 | 88.77 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 88.75 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 88.47 | gold quality |
| amygdala | UBERON:0001876 | 88.29 | gold quality |
| temporal lobe | UBERON:0001871 | 88.12 | gold quality |
| substantia nigra | UBERON:0002038 | 88.03 | gold quality |
| lymph node | UBERON:0000029 | 87.93 | gold quality |
| Ammon’s horn | UBERON:0001954 | 87.86 | gold quality |
| apex of heart | UBERON:0002098 | 87.74 | gold quality |
| prostate gland | UBERON:0002367 | 87.65 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.19 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.